Unpacking Endometrial Cancer with Professor Linda Mileshkin
Endometrial cancer is the most common gynaecological cancer in Australia and advanced disease and early…
Browsing: Featured
Molecular ‘super-glue’ shows promise of cancer drug discovery platform
Today, St. Jude Children’s Research Hospital scientists published their work on SJ3149, a compound with…
The OJC Meets Chris Booth
The Oncology Network is delighted to share the return of The OJC Meets, sister series of The Oncology…
Blood test distinguishes neuroendocrine subtype of advanced prostate cancer
Like a criminal entering a witness protection program, cancer cells can shed their past and…
Drinkable, carbon monoxide-infused foam enhances effectiveness of experimental cancer therapy
Did smokers do better than non-smokers in a clinical trial for an experimental cancer treatment?…
Obesity linked to detection of blood cancer precursor
Individuals with obesity are more likely to have monoclonal gammopathy of undetermined significance (MGUS), a…
Scientists tame chaotic protein fuelling 75% of cancers
Meet MYC, the shapeless protein responsible for making the majority of human cancer cases worse.…
The world’s first prototype for real-time tracking of moving tumours using magnetic resonance imaging (MRI) during proton therapy goes into scientific application
On January 9th, 2024, a scientific prototype for MRI-guided proton therapy was inaugurated in Dresden.…
Sex-specific panel of 10 proteins can pick up 18 different early stage cancers
A sex-specific panel of 10 proteins can pick up 18 different early stage cancers, representing…
Epigenetic therapy shows promise for endocrine-resistant breast cancer
Endocrine resistance – a major cause of breast cancer deaths – can be underpinned by…